The archive · Health & Care · Product decision · 2024-2026
Carevision bets a phone camera can replace clinic visits for cardiometabolic screening
Jordanian startup turns any phone camera into a 60-second cardiometabolic risk scanner; 500 Global/Sanabil grad now anchored by 2080 Ventures.
Carevision
What the business is
An AI healthtech platform that turns any smartphone camera into a 60-second cardiometabolic risk scanner for early detection of heart and metabolic disease risk.
How it started
Founded in 2024 by Amani Abulaban in Jordan, Carevision set out to make preventive screening accessible to everyone by building infrastructure for wellness at scale - early detection of cardiometabolic risk before conditions escalate.
What happened
Carevision was selected for the 11th cohort of the Sanabil Accelerator by 500 Global (April 5 - July 1, 2026), one of eight startups chosen from more than 690 applications, described as an AI platform that transforms any smartphone camera into a 60-second cardiometabolic risk scanner. It presented at Demo Day in Riyadh on July 1, 2026. The company also opened a seed round after participating in the Jordan x 2080 Accelerator's Demo Day in Amman, with 2080 Ventures contributing capital as anchor investor.
How it ended up
Still live and raising: Carevision completed the 500 Global/Sanabil cohort in July 2026, and its seed round remains open with 2080 Ventures as anchor investor.
Background
Carevision is a Jordanian healthtech startup founded in 2024 by Amani Abulaban with the mission of making preventive screening accessible to everyone. Its product is an AI platform that turns any smartphone camera into a 60-second cardiometabolic risk scanner, aimed at early detection of heart and metabolic disease risk before conditions escalate.
In 2026 the company joined the 11th cohort of the Sanabil Accelerator by 500 Global, the joint program of 500 Global and Sanabil Investments, a company owned by Saudi Arabia's Public Investment Fund. One of eight startups chosen from more than 690 applications, Carevision completed the hybrid program from April 5 to July 1 and presented at Demo Day in Riyadh.
Around the same period it opened a seed round after participating in the Jordan x 2080 Accelerator's Demo Day in Amman, with 2080 Ventures structuring and anchoring the round alongside MENA and US co-investors; the investment announcement came on the heels of completing the 500 Global/Sanabil cohort.
The bet is that the camera in everyone's pocket plus AI is enough to make screening a mass-market product - no device, no lab visit - and that proving it in MENA, where many places lack easy access to a clinic, can scale globally.
What has to be true
- A smartphone scan removes the biggest barriers to screening: no device to buy, no clinic visit, no lab appointment.
- MENA is a good proving ground because clinic access is thin in many areas, so the 60-second scan addresses a felt problem rather than a hypothetical one.
- Accelerator sequencing bought Carevision capital access: the 500 Global/Sanabil program opened investor doors, and 2080 Ventures anchored its seed round.
What can be applied
Pick the wedge the market can already hold: by making the phone the diagnostic device, Carevision needed no new hardware or lab infrastructure to reach users in markets with thin clinic access.
Aftermath
As of September 2026, Carevision is a seed-stage company, still raising. It completed the Sanabil Accelerator by 500 Global's 11th cohort in July 2026, then announced an investment from 2080 Ventures, which anchored its open seed round alongside MENA and US co-investors. The company's focus remains the smartphone-based cardiometabolic risk scan, targeting preventive wellness at scale in markets without easy clinic access.
Sources
- 500 Global and Sanabil back eight startups in latest accelerator cohort
- Sanabil Accelerator By 500 Global Graduates Eight Startups
- Jordanian AI Healthtech Carevision Lands Investment from 2080 Ventures
spotted an error? The archive wants to know.
Your turn
You just read one. Describe what you are building, and see who is betting on the same thing.
Free account · 3 free questions · no card